Bath Reconciled Depreciation vs Total Operating Expenses Analysis

BBWI Stock

USD 45.97 2.14 4.88%

Bath Body financial indicator trend analysis is way more than just evaluating Bath Body Works prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Bath Body Works is a good investment. Please check the relationship between Bath Body Reconciled Depreciation and its Total Operating Expenses accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bath Body Works. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in housing.

Reconciled Depreciation vs Total Operating Expenses

Reconciled Depreciation vs Total Operating Expenses Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Bath Body Works Reconciled Depreciation account and Total Operating Expenses. At this time, the significance of the direction appears to have weak relationship.

The correlation between Bath Body's Reconciled Depreciation and Total Operating Expenses is 0.31. Overlapping area represents the amount of variation of Reconciled Depreciation that can explain the historical movement of Total Operating Expenses in the same time period over historical financial statements of Bath Body Works, assuming nothing else is changed. The correlation between historical values of Bath Body's Reconciled Depreciation and Total Operating Expenses is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Reconciled Depreciation of Bath Body Works are associated (or correlated) with its Total Operating Expenses. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Operating Expenses has no effect on the direction of Reconciled Depreciation i.e., Bath Body's Reconciled Depreciation and Total Operating Expenses go up and down completely randomly.

Correlation Coefficient

0.31

Relationship Direction	Positive
Relationship Strength	Very Weak

View All Relationships

Reconciled Depreciation

Total Operating Expenses

The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.

Most indicators from Bath Body's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Bath Body Works current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bath Body Works. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in housing.

As of now, Bath Body's Enterprise Value Multiple is increasing as compared to previous years. The Bath Body's current Enterprise Value is estimated to increase to about 5.7 B, while Discontinued Operations is projected to decrease to under 5.1 M.

	2021	2022	2023	2024 (projected)
Gross Profit	3.9B	3.3B	3.2B	3.4B
Total Revenue	7.9B	7.6B	7.4B	9.2B

Gross Profit Total Revenue

Bath Body fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Accounts Payable	Short Term Debt	Common Stock	Current Deferred Revenue	Intangible Assets	Common Stock Total Equity
Total Assets		0.87	0.9	0.99	-0.12	0.86	0.71	-0.2	0.82	0.96	0.02	0.82	0.8	-0.65	0.91	0.89	0.55	0.14	0.94	0.93	0.89	0.58	-0.33	-0.27	0.63	-0.53
Short Long Term Debt Total	0.87		0.62	0.86	-0.43	0.9	0.84	-0.49	0.75	0.85	-0.23	0.75	0.69	-0.71	0.98	0.62	0.2	0.28	0.97	0.77	0.64	0.68	-0.58	-0.28	0.35	-0.64
Other Current Liab	0.9	0.62		0.91	0.16	0.63	0.41	0.13	0.74	0.82	0.23	0.74	0.7	-0.46	0.72	0.89	0.65	-0.08	0.77	0.87	0.92	0.34	-0.03	-0.15	0.77	-0.29
Total Current Liabilities	0.99	0.86	0.91		-0.1	0.85	0.7	-0.19	0.78	0.96	0.06	0.78	0.79	-0.63	0.91	0.9	0.54	0.16	0.94	0.9	0.89	0.58	-0.31	-0.23	0.67	-0.5
Total Stockholder Equity	-0.12	-0.43	0.16	-0.1		-0.32	-0.71	0.88	-0.05	-0.17	0.72	-0.05	-0.3	0.54	-0.36	0.0	0.18	-0.24	-0.31	-0.04	0.02	-0.32	0.79	0.47	0.49	0.67
Property Plant And Equipment Net	0.86	0.9	0.63	0.85	-0.32		0.87	-0.47	0.61	0.91	-0.22	0.61	0.64	-0.47	0.86	0.68	0.2	0.41	0.87	0.68	0.61	0.76	-0.36	-0.02	0.37	-0.42
Net Debt	0.71	0.84	0.41	0.7	-0.71	0.87		-0.76	0.44	0.79	-0.42	0.44	0.67	-0.67	0.8	0.59	0.19	0.4	0.79	0.53	0.5	0.72	-0.67	-0.35	0.1	-0.7
Retained Earnings	-0.2	-0.49	0.13	-0.19	0.88	-0.47	-0.76		-0.09	-0.26	0.72	-0.09	-0.33	0.43	-0.39	-0.07	0.18	-0.66	-0.36	-0.09	0.01	-0.47	0.77	0.25	0.43	0.59
Cash	0.82	0.75	0.74	0.78	-0.05	0.61	0.44	-0.09		0.62	-0.12	1.0	0.51	-0.48	0.75	0.56	0.24	0.04	0.77	0.95	0.61	0.46	-0.25	-0.19	0.33	-0.38
Non Current Assets Total	0.96	0.85	0.82	0.96	-0.17	0.91	0.79	-0.26	0.62		0.04	0.62	0.81	-0.63	0.9	0.9	0.55	0.2	0.93	0.78	0.86	0.61	-0.34	-0.24	0.66	-0.52
Non Currrent Assets Other	0.02	-0.23	0.23	0.06	0.72	-0.22	-0.42	0.72	-0.12	0.04		-0.12	-0.15	0.1	-0.13	0.21	0.45	-0.38	-0.09	-0.02	0.21	-0.04	0.49	0.0	0.68	0.28
Cash And Short Term Investments	0.82	0.75	0.74	0.78	-0.05	0.61	0.44	-0.09	1.0	0.62	-0.12		0.51	-0.48	0.75	0.56	0.24	0.04	0.77	0.95	0.61	0.46	-0.25	-0.19	0.33	-0.38
Net Receivables	0.8	0.69	0.7	0.79	-0.3	0.64	0.67	-0.33	0.51	0.81	-0.15	0.51		-0.74	0.79	0.83	0.66	0.15	0.8	0.69	0.88	0.2	-0.51	-0.45	0.5	-0.67
Common Stock Shares Outstanding	-0.65	-0.71	-0.46	-0.63	0.54	-0.47	-0.67	0.43	-0.48	-0.63	0.1	-0.48	-0.74		-0.78	-0.58	-0.47	0.04	-0.76	-0.58	-0.63	-0.29	0.83	0.83	-0.31	0.96
Non Current Liabilities Total	0.91	0.98	0.72	0.91	-0.36	0.86	0.8	-0.39	0.75	0.9	-0.13	0.75	0.79	-0.78		0.72	0.37	0.18	1.0	0.82	0.77	0.58	-0.56	-0.35	0.48	-0.67
Inventory	0.89	0.62	0.89	0.9	0.0	0.68	0.59	-0.07	0.56	0.9	0.21	0.56	0.83	-0.58	0.72		0.8	0.07	0.77	0.78	0.95	0.39	-0.19	-0.32	0.75	-0.45
Other Current Assets	0.55	0.2	0.65	0.54	0.18	0.2	0.19	0.18	0.24	0.55	0.45	0.24	0.66	-0.47	0.37	0.8		-0.15	0.41	0.48	0.8	-0.02	-0.07	-0.42	0.69	-0.35
Other Stockholder Equity	0.14	0.28	-0.08	0.16	-0.24	0.41	0.4	-0.66	0.04	0.2	-0.38	0.04	0.15	0.04	0.18	0.07	-0.15		0.18	0.04	-0.04	0.43	-0.31	0.28	-0.16	-0.11
Total Liab	0.94	0.97	0.77	0.94	-0.31	0.87	0.79	-0.36	0.77	0.93	-0.09	0.77	0.8	-0.76	1.0	0.77	0.41	0.18		0.85	0.81	0.59	-0.52	-0.33	0.53	-0.65
Total Current Assets	0.93	0.77	0.87	0.9	-0.04	0.68	0.53	-0.09	0.95	0.78	-0.02	0.95	0.69	-0.58	0.82	0.78	0.48	0.04	0.85		0.81	0.47	-0.27	-0.29	0.51	-0.47
Accounts Payable	0.89	0.64	0.92	0.89	0.02	0.61	0.5	0.01	0.61	0.86	0.21	0.61	0.88	-0.63	0.77	0.95	0.8	-0.04	0.81	0.81		0.23	-0.22	-0.35	0.78	-0.47
Short Term Debt	0.58	0.68	0.34	0.58	-0.32	0.76	0.72	-0.47	0.46	0.61	-0.04	0.46	0.2	-0.29	0.58	0.39	-0.02	0.43	0.59	0.47	0.23		-0.27	-0.01	0.12	-0.29
Common Stock	-0.33	-0.58	-0.03	-0.31	0.79	-0.36	-0.67	0.77	-0.25	-0.34	0.49	-0.25	-0.51	0.83	-0.56	-0.19	-0.07	-0.31	-0.52	-0.27	-0.22	-0.27		0.68	0.16	0.93
Current Deferred Revenue	-0.27	-0.28	-0.15	-0.23	0.47	-0.02	-0.35	0.25	-0.19	-0.24	0.0	-0.19	-0.45	0.83	-0.35	-0.32	-0.42	0.28	-0.33	-0.29	-0.35	-0.01	0.68		-0.11	0.84
Intangible Assets	0.63	0.35	0.77	0.67	0.49	0.37	0.1	0.43	0.33	0.66	0.68	0.33	0.5	-0.31	0.48	0.75	0.69	-0.16	0.53	0.51	0.78	0.12	0.16	-0.11		-0.1
Common Stock Total Equity	-0.53	-0.64	-0.29	-0.5	0.67	-0.42	-0.7	0.59	-0.38	-0.52	0.28	-0.38	-0.67	0.96	-0.67	-0.45	-0.35	-0.11	-0.65	-0.47	-0.47	-0.29	0.93	0.84	-0.1

Click cells to compare fundamentals

Bath Body Account Relationship Matchups

Bath Body fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	10.1B	11.6B	6.0B	5.5B	5.5B	6.2B
Short Long Term Debt Total	9.1B	9.5B	6.0B	6.1B	5.6B	2.9B
Other Current Liab	856M	1.2B	537M	552M	530M	707.7M
Total Current Liabilities	2.4B	2.8B	1.3B	1.4B	1.3B	1.4B
Total Stockholder Equity	(1.5B)	(662M)	(1.5B)	(2.2B)	(1.6B)	(1.5B)
Property Plant And Equipment Net	5.5B	4.7B	2.0B	2.2B	2.3B	2.1B
Net Debt	7.6B	5.6B	4.0B	4.8B	4.5B	4.7B
Retained Earnings	(2.2B)	(1.4B)	(1.8B)	(2.4B)	(1.8B)	(1.7B)
Cash	1.5B	3.9B	2.0B	1.2B	1.1B	1.2B
Non Current Assets Total	6.9B	6.0B	3.0B	3.2B	3.3B	3.4B
Non Currrent Assets Other	100M	112M	23M	31M	15M	14.3M
Cash And Short Term Investments	1.5B	3.9B	2.0B	1.2B	1.1B	1.2B
Net Receivables	306M	269M	240M	226M	224M	240.9M
Common Stock Shares Outstanding	276M	281M	273M	233M	229M	376.6M
Liabilities And Stockholders Equity	10.1B	11.6B	6.0B	5.5B	5.5B	6.2B
Non Current Liabilities Total	9.2B	9.4B	6.3B	6.3B	5.8B	3.5B
Inventory	1.2B	1.3B	1.3B	709M	710M	1.1B
Other Current Assets	153M	134M	81M	99M	97M	179.3M
Other Stockholder Equity	489M	533M	71M	(4M)	15M	15.8M
Total Liab	11.6B	12.2B	7.5B	7.7B	7.1B	4.9B
Total Current Assets	3.2B	5.6B	3.0B	2.3B	2.1B	2.8B
Short Term Debt	539M	594M	170M	177M	181M	216.8M
Common Stock	142M	143M	134M	122M	120M	148.6M
Current Deferred Revenue	330M	361M	148M	195M	198M	206.4M
Common Stock Total Equity	142M	143M	134M	122M	109.8M	148.7M
Property Plant And Equipment Gross	5.5B	4.7B	3.6B	2.2B	4.2B	2.7B
Accumulated Other Comprehensive Income	52M	83M	80M	78M	75M	78.8M
Other Liab	696M	524M	410M	444M	399.6M	592.9M
Net Tangible Assets	(2.5B)	(1.7B)	(2.5B)	(2.0B)	(2.3B)	(2.4B)
Other Assets	164M	184M	181M	68M	61.2M	105.1M
Long Term Debt	5.5B	6.4B	4.9B	4.9B	4.4B	4.3B
Net Invested Capital	4.0B	5.7B	3.3B	4.9B	2.8B	3.5B
Non Current Liabilities Other	490M	311M	253M	276M	261M	402.2M
Net Working Capital	873M	2.8B	1.7B	887M	826M	1.1B
Property Plant Equipment	5.5B	4.7B	1.0B	1.2B	1.1B	1.0B

Pair Trading with Bath Body

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bath Body position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bath Body will appreciate offsetting losses from the drop in the long position's value.

Moving together with Bath Stock

0.61

Wayfair

Pair Corr

The ability to find closely correlated positions to Bath Body could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bath Body when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bath Body - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bath Body Works to buy it.

The correlation of Bath Body is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bath Body moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bath Body Works moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Bath Body can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Bath Body Works offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bath Body's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bath Body Works Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bath Body Works Stock:

How To Invest In Bath

Details

Is Bath Stock a good investment?

Details

What is Bath Body's Net Worth?

Details

Largest Consumer Discretionary Distribution & Retail Companies

View

Largest Consumer Discretionary Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bath Body Works. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in housing.

You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for Bath Stock analysis

When running Bath Body's price analysis, check to measure Bath Body's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bath Body is operating at the current time. Most of Bath Body's value examination focuses on studying past and present price action to predict the probability of Bath Body's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bath Body's price. Additionally, you may evaluate how the addition of Bath Body to your portfolios can decrease your overall portfolio volatility.

	Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon
	Money Managers Screen money managers from public funds and ETFs managed around the world
	Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators
	Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum
	Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account
	Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk
	Economic Indicators Top statistical indicators that provide insights into how an economy is performing
	Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios
	Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance

Is Bath Body's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bath Body. If investors know Bath will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bath Body listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.352

Dividend Share

0.8

Earnings Share

3.84

Revenue Per Share

32.583

Quarterly Revenue Growth

0.008

The market value of Bath Body Works is measured differently than its book value, which is the value of Bath that is recorded on the company's balance sheet. Investors also form their own opinion of Bath Body's value that differs from its market value or its book value, called intrinsic value, which is Bath Body's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bath Body's market value can be influenced by many factors that don't directly affect Bath Body's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Bath Body's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bath Body is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bath Body's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Bath Reconciled Depreciation vs Total Operating Expenses Analysis

Reconciled Depreciation vs Total Operating Expenses

Reconciled Depreciation vs Total Operating Expenses Correlation Analysis

Correlation Coefficient

Reconciled Depreciation

Total Operating Expenses

Bath Body fundamental ratios Correlations

Bath Body Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Bath Body fundamental ratios Accounts

Pair Trading with Bath Body

Moving together with Bath Stock

Complementary Tools for Bath Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Total Liab	+ 1.0	Non Current Liabilities Total
Total Current Liabilities	+ 0.99	Total Assets
Non Current Liabilities Total	+ 0.98	Short Long Term Debt Total
Total Liab	+ 0.97	Short Long Term Debt Total
Non Current Assets Total	+ 0.96	Total Assets

Non Current Liabilities Total	- 0.78	Common Stock Shares Outstanding
Total Liab	- 0.76	Common Stock Shares Outstanding
Retained Earnings	- 0.76	Net Debt
Common Stock Shares Outstanding	- 0.74	Net Receivables
Net Debt	- 0.71	Total Stockholder Equity
Common Stock Shares Outstanding	- 0.71	Short Long Term Debt Total